Primary |
Constipation |
54.2% |
Drug Use For Unknown Indication |
25.0% |
Colonoscopy |
8.3% |
Abdominal Pain |
4.2% |
Intestinal Obstruction |
4.2% |
Irritable Bowel Syndrome |
4.2% |
|
Gastrointestinal Hypomotility |
9.5% |
Pharmaceutical Product Complaint |
9.5% |
Talipes |
9.5% |
Therapeutic Response Unexpected With Drug Substitution |
9.5% |
Diabetes Mellitus |
4.8% |
Gastrointestinal Obstruction |
4.8% |
Intestinal Obstruction |
4.8% |
Malaise |
4.8% |
Obsessive-compulsive Disorder |
4.8% |
Parosmia |
4.8% |
Rash Pruritic |
4.8% |
Reaction To Drug Excipients |
4.8% |
Speech Disorder Developmental |
4.8% |
Swelling Face |
4.8% |
Treatment Noncompliance |
4.8% |
Vomiting |
4.8% |
Wound Haemorrhage |
4.8% |
|
Secondary |
Drug Use For Unknown Indication |
42.1% |
Constipation |
36.8% |
Hypothyroidism |
10.5% |
Breast Cancer Metastatic |
5.3% |
Ileus Paralytic |
5.3% |
|
Talipes |
50.0% |
Alopecia |
8.3% |
Intestinal Obstruction |
8.3% |
Mania |
8.3% |
Pharyngeal Oedema |
8.3% |
Pregnancy |
8.3% |
Rash |
8.3% |
|
Concomitant |
Product Used For Unknown Indication |
25.9% |
Drug Use For Unknown Indication |
10.6% |
Pain |
9.3% |
Constipation |
8.7% |
Hypertension |
5.8% |
Depression |
4.7% |
Gastrooesophageal Reflux Disease |
4.3% |
Osteoporosis |
4.3% |
Chronic Obstructive Pulmonary Disease |
3.1% |
Back Pain |
2.9% |
Multiple Myeloma |
2.9% |
Anxiety |
2.7% |
Fatigue |
2.3% |
Multiple Sclerosis |
2.1% |
Panic Attack |
2.0% |
Breast Cancer |
1.7% |
Hypercalcaemia |
1.7% |
Breast Cancer Metastatic |
1.6% |
Nausea |
1.6% |
Sleep Disorder |
1.6% |
|
Weight Decreased |
12.4% |
Weight Increased |
10.4% |
Vomiting |
9.1% |
Wheezing |
7.9% |
Urinary Tract Infection |
7.1% |
White Blood Cell Count Decreased |
6.6% |
Wound Infection Staphylococcal |
5.8% |
Wound Drainage |
4.6% |
Wrist Fracture |
4.6% |
Pneumonia |
3.7% |
White Blood Cell Count Increased |
3.7% |
Pain In Extremity |
3.3% |
Sleep Apnoea Syndrome |
3.3% |
Unresponsive To Stimuli |
2.9% |
Ventricular Fibrillation |
2.9% |
Intestinal Perforation |
2.5% |
Therapeutic Agent Toxicity |
2.5% |
Type 2 Diabetes Mellitus |
2.5% |
Pain |
2.1% |
Syncope |
2.1% |
|